Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bioscience, DeepCDR Collaborate on Antibody Library Design

NEW YORK – Twist Bioscience said on Thursday that it is collaborating with DeepCDR, a company applying deep learning algorithms to antibody discovery and optimization.

"DeepCDR offers a unique approach enabled by deep learning to generate large panels of fully human antibody sequences," Twist cofounder and CEO Emily Leproust said in a statement. "Utilizing these sequences, we've built multiple fully human naive synthetic antibody libraries — specifically, AI Hypermutated single-chain fragment variable (scFv) library and a new coronavirus-specific scFv library — to add to our ever-growing Library of Libraries."

Financial and other details of the deal were not disclosed.

Basel, Switzerland-based DeepCDR combines machine learning methods with a proprietary mammalian display platform to identify and select antibodies with high affinity and developability profiles.

Twist has used its synthetic antibody phage display libraries to ink multiple collaboration deals over the last few years.

Last month, it signed a deal with SomaLogic to identify antibodies against targets identified with the SomaScan proteomics platform. In April, Twist partnered with Pure Biologics, giving that firm access to select libraries, and last year, it licensed its libraries to Japan's Takeda Pharmaceutical.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.